Oncolytics Biotech Reports Data in Colorectal Cancer Study
By Karen Roman Oncolytics Biotech Inc. (Nasdaq: ONCY) said it has new data showing the use of pelareorep in metastatic colorectal cancer has a 19.5-month median...
High Times Ties Up with Lucy Scientific in Going-Public Transaction on Nasdaq
-High Times Holdings Corp. to exchange core IP assets for 19.9% stake in Lucy Scientific...
Full Agenda: 3rd Palm Beach CorpGov Forum Featuring PE Edge with NYSE, Goodmans, Goldman Sachs Nov. 8
The third annual Palm Beach CorpGov Forum will held on Wednesday, Nov. 8, for a full...
QuantaSing Recognized as China’s Largest Online Individual Adult Learning Service
By IPO Edge Editorial QuantaSing Group Ltd (NASDAQ: QSG) was acknowledged as the largest online...
Sempra Expects Significant Growth Ahead for Energy Infrastructure and Announced Stock Split
Sempra Vice President of Investor Relations Glen Donovan By IPO Edge Editorial Sempra, a leading...
HIGHLIGHTS – Taking EVs Off Highway: Insights from ZeroNox Fireside Chat
IPO Edge and the Palm Beach Hedge Fund Association hosted a fireside chat with ZeroNox to discuss the business...
REPLAY – Clean Energy Future: Insights from ZeroNox in Fireside Chat
IPO Edge and the Palm Beach Hedge Fund Association hosted a fireside chat with ZeroNox to...
INTERVIEW: PublicSq. CEO Forecasts Swing to Positive Cash Flow in 2024; Reports 12x Sales Jump in 1H 2023
Newly-listed PSQ Holdings, Inc. (NYSE: PSQH) expects to swing to cash flow positive in 2024;...
